News
US to Initially Impose 'Small Tariff' on Pharma Imports, Trump Says
President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical imports before hiking it to 150% within 18 months and eventually to 250% in an effort to boost domestic production.
Trump sounds off on lowering U.S. drug prices, threatens steep tariffs on pharmaceuticals
President Trump said he wants to lower the cost of U.S. drug prices and threatened to impose tariffs on pharmaceuticals that could reach up to 250%. CBS News MoneyWatch correspondent Kelly O'Grady breaks it down.
In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...
The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy ...
Pharmaceutical Technology on MSN5d
Trump doubles down on Most Favored Nation plan to target drug pricesMajor pharma manufacturers have a 29 September deadline to adjust their drug prices relative to other developed countries.
One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...
The Trump administration is planning to pilot covering weight loss drugs. A longtime healthcare exec moves to a strategic advisory role at General Catalyst.
Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.
The New Republic on MSN1d
Trump Fumbles Basic Math Concept Trying to Brag About Drug PricesTrump’s first-term rule—“Most Favored Nation”—was focused on lowering the cost of Medicare payments on certain drugs, but the ...
President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to ...
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
AlterNet on MSN1d
'Astronomical': Senate Dems rip GOP's sneaky planRon Wyden (D-Ore.) and Catherine Cortez Masto (D-Nev.) pointed out that the budget package "includes provisions that block or ...
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback